Across cohorts, higher IMAT correlates with lower insulin sensitivity and poorer muscle quality in established obesity/T2DM, and human biopsy/co-culture studies show paracrine impairment of myofiber insulin action [39]. The gene discussed is INS; the disease is type 2 diabetes mellitus.